BOD 0.00% 2.4¢ bod science limited

S3 First Mover Advantage, page-2

  1. 759 Posts.
    lightbulb Created with Sketch. 39
    my honest opinion and its just my opinion is that CAN started off as a growing company and when they realise that growing wasnt going to pay off as they first thought. they've quickly rushed through a product without any real testing, when other companies have has product testing in the special access scheme and years of r&d. this is why they've been rejected.. CAN has no real direction anymore and heavily in debt and just trying anything now

    in saying that i hope bod gets it right as they had years of r&d and S.A.S experience in this field now..

    still as i said not going to count my chickens before i actually see a stamped approval from the tga.. fingers cross.
 
watchlist Created with Sketch. Add BOD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.